Clinical trial
A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
NCT02661464 is registered in ClinicalTrials.gov with Janssen Vaccines & Prevention B.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
- Lead sponsor
- Janssen Vaccines & Prevention B.V.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 31, 2016
- Completion date
- December 13, 2021
- Enrollment
- 677 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.